Meet our panelists:

Hanna Wabnitz, PhD –  Scientific Communications Specialist, The Princess Margaret Cancer Foundation

• Originally from Germany, Hanna has spent the last 11 years living abroad. Following a work and travel year in Australia, Hanna moved to the UK where she completed her BSc in Cancer Biology and Immunology at the University of Bristol. During that time , Hanna was selected for the prestigious Amgen Scholars Program, allowing her to complete a summer research project in the laboratory of Professor Tadatsugu Taniguchi at the University of Tokyo.
  In 2018, Hanna moved to Canada to pursue a Direct-Entry PhD in Immunology and Hematology at the University of Toronto from which she graduated last year. During her PhD, she developed a novel mouse model that allows the study of previously disregarded factors in RBC alloimmunization and hemolytic disease of the fetus and newborn.
  Throughout her PhD, Hanna discovered her love for science communication. She was the Site Coordinator for Classroom Outreach and Communication for the Let’s Talk Science St. George site, helping to promote and organize their science education and outreach program across the GTA. Additionally, Hanna won the University of Toronto’s Most Understandable Scientist competition in 2021.
  Now, she uses those skills as well as her scientific training in her role as a Scientific Communications Specialist at The Princess Margaret Cancer Foundation. Her work involves writing donor-centred proposals and impact reports, interviewing clinicians and researchers and translating groundbreaking science into lay language in order to raise money for cancer research and care at The Princess Margaret.

Nadine Tan, MScBMC –  Medical/Scientific Editor, The New England Journal of Medicine

• Nadine is a biomedical communication expert with a unique blend of science, art and design expertise.
  She works as a medical & scientific illustrator at the New England Journal of Medicine, where she
  develops illustrations and animations for medical practitioners. Nadine is a graduate of the Biomedical
  Communications Program (MScBMC) at the University of Toronto, one of four internationally accredited
  medical illustration programs in the field. Before this, she completed her undergraduate degree in
  Biochemistry (BSc) at York University, and two years of classical art training at the Academy of Realist Art,
  Toronto.

Laura Kuhlmann, PhD –  Medical Writer, National Cancer Institute

• Dr. Laura Kuhlmann is a cancer biologist and medical writer, currently working as a contractor at the National Cancer Institute (NCI) in Maryland, USA. She obtained her PhD in biology from the University of Heidelberg, Germany, where she specialized in cell-surface proteomics. She subsequently pursued a postdoc (2016-2021) at the Princess Margaret Cancer Centre, at the UHN in the lab of Dr. Thomas Kislinger. While in Toronto, Laura embraced her passion for writing by first becoming a member of the Toronto Writers Co-Operative operating at the Toronto Public Library. In 2019, Laura joined the Office of Research Trainees (ORT) as a volunteer writer for the ORT Times and transitioned to a contracted science writer position in 2020.  In 2021 Laura joined the Division of Cancer Treatment and Diagnosis (DCTD) at the NCI, where she works together with oncology clinical specialists to launch, manage, and report the results of early-phase clinical trials run at the NCI.

Candice Tang, MSc –  Principal Medical Writer, Six Degrees Medical

• Candice Tang is a Principal Medical Writer at Six Degrees Medical – A Reverba® Company. She works across a global portfolio of medical writing and science communication projects for pharma clients. Her focus areas include medical education, speaker training, medical strategy, and KOL engagement in diverse therapeutic areas. She previously worked as a Life Sciences Journalist at a webinar marketing firm and a Research Communications Intern at a non-profit organization. At the labs of Drs. Slava Epelman (TGHRI) and Milica Radisic (UofT’s IBBME), she investigated immune reactions to biomaterials in mouse models of acute ischemic injury.